The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 24, 2024
Filed:
Jul. 20, 2023
Applicant:
Orphai Therapeutics Inc., Guilford, CT (US);
Inventors:
Henri Lichenstein, Guilford, CT (US);
Jonathan M. Rothberg, Guilford, CT (US);
Thomas Armer, Palo Alto, CA (US);
Lawrence S. Melvin, Jr., Niwot, CO (US);
Assignee:
OrphAI Therapeutics Inc., Guilford, CT (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 31/436 (2006.01); A61K 31/445 (2006.01); A61K 45/06 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0075 (2013.01); A61K 9/0078 (2013.01); A61K 9/14 (2013.01); A61K 9/145 (2013.01); A61K 9/1623 (2013.01); A61K 31/436 (2013.01); A61K 31/445 (2013.01); A61K 45/06 (2013.01); A61K 47/26 (2013.01);
Abstract
The present invention relates to methods and compositions for treating lymphangioleiomyomatosis in a human subject in need of such treatment. The methods comprise administering to the subject via inhalation an aerosol composition comprising rapamycin or a prodrug or derivative (including analog) thereof.